The Drug Development Institute is led by a team of highly experienced research and drug development scientists with:
- Diversified industrial experience along the drug development value chain
- Proven track records of delivering novel compounds and technologies for clinical development
- Experience in managing projects using data-driven, milestone-based project management
Erandi De Silva, PhD – Molecular Biologist
Email: firstname.lastname@example.org | Phone: 614-685-8869
Dr. De Silva earned her PhD in molecular biology at Princeton and completed her postdoctoral research at Genentech. Erandi brings biology and project-management experience to the DDI.
Chad Bennett, PhD – Medicinal & Process Chemist
Email: email@example.com | Phone: 614-685-9230
Dr. Bennett has over 10 years of experience in the pharmaceutical industry at Merck and Schering-Plough, working in both the discovery and early-development phases.
Larry Schaaf, PhD – Clinical Pharmacologist
Email: firstname.lastname@example.org | Phone: 614-293-6851
Dr. Schaaf has more than 25 years of experience performing clinical pharmacology assessments in the pharmaceutical industry and academia. Larry has held positions within Upjohn, Pharmacia and Pfizer, and he directed the OSUCCC – James Phase I Unit for 11 years.
Cindy Evans – Administrative Assistant
Email: email@example.com | Phone: 614-685-6957
For more information, contact the DDI team members individually or at firstname.lastname@example.org.